The Evidence for Caries Management by Risk Assessment (CAMBRA®).

Q1 Medicine Advances in Dental Research Pub Date : 2018-02-01 DOI:10.1177/0022034517736500
J D B Featherstone, B W Chaffee
{"title":"The Evidence for Caries Management by Risk Assessment (CAMBRA®).","authors":"J D B Featherstone,&nbsp;B W Chaffee","doi":"10.1177/0022034517736500","DOIUrl":null,"url":null,"abstract":"<p><p>A system for Caries Management by Risk Assessment (CAMBRA<sup>®</sup>) has been developed in California. The purpose of this article is to summarize the science behind the methodology, the history of the development of CAMBRA, and the outcomes of clinical application. The CAMBRA caries risk assessment (CRA) tool for ages 6 y through adult has been used at the University of California, San Francisco (UCSF), for 14 y, and outcome studies involving thousands of patients have been conducted. Three outcomes assessments, each on different patient cohorts, demonstrated a clear relationship between CAMBRA-CRA risk levels of low, moderate, high, and extreme with cavitation or lesions into dentin (by radiograph) at follow-up. This validated risk prediction tool has been updated with time and is now routinely used at UCSF and in other settings worldwide as part of normal clinical practice. The CAMBRA-CRA tool for 0- to 5-y-olds has demonstrated similar predictive validity and is in routine use. The addition of chemical therapy (antibacterial plus fluoride) to the traditional restorative treatment plan, based on caries risk status, has been shown to reduce the caries increment by about 20% to 38% in high-caries-risk adult patients. The chemical therapy used for high-risk patients is a combination of daily antibacterial therapy (0.12% w/v chlorhexidine gluconate mouth rinse) and twice-daily high-concentration fluoride toothpaste (5,000 ppm F), both for home use. These outcomes assessments provide the evidence to use these CRA tools with confidence. Caries can be managed by adding chemical therapy, based on the assessed caries risk level, coupled with necessary restorative procedures. For high- and extreme-risk patients, a combination of antibacterial and fluoride therapy is necessary. The fluoride therapy must be supplemented by antibacterial therapy to reduce the bacterial challenge, modify the biofilm, and provide prevention rather than continued caries progression.</p>","PeriodicalId":7300,"journal":{"name":"Advances in Dental Research","volume":"29 1","pages":"9-14"},"PeriodicalIF":0.0000,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/0022034517736500","citationCount":"96","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Dental Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0022034517736500","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 96

Abstract

A system for Caries Management by Risk Assessment (CAMBRA®) has been developed in California. The purpose of this article is to summarize the science behind the methodology, the history of the development of CAMBRA, and the outcomes of clinical application. The CAMBRA caries risk assessment (CRA) tool for ages 6 y through adult has been used at the University of California, San Francisco (UCSF), for 14 y, and outcome studies involving thousands of patients have been conducted. Three outcomes assessments, each on different patient cohorts, demonstrated a clear relationship between CAMBRA-CRA risk levels of low, moderate, high, and extreme with cavitation or lesions into dentin (by radiograph) at follow-up. This validated risk prediction tool has been updated with time and is now routinely used at UCSF and in other settings worldwide as part of normal clinical practice. The CAMBRA-CRA tool for 0- to 5-y-olds has demonstrated similar predictive validity and is in routine use. The addition of chemical therapy (antibacterial plus fluoride) to the traditional restorative treatment plan, based on caries risk status, has been shown to reduce the caries increment by about 20% to 38% in high-caries-risk adult patients. The chemical therapy used for high-risk patients is a combination of daily antibacterial therapy (0.12% w/v chlorhexidine gluconate mouth rinse) and twice-daily high-concentration fluoride toothpaste (5,000 ppm F), both for home use. These outcomes assessments provide the evidence to use these CRA tools with confidence. Caries can be managed by adding chemical therapy, based on the assessed caries risk level, coupled with necessary restorative procedures. For high- and extreme-risk patients, a combination of antibacterial and fluoride therapy is necessary. The fluoride therapy must be supplemented by antibacterial therapy to reduce the bacterial challenge, modify the biofilm, and provide prevention rather than continued caries progression.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过风险评估(CAMBRA®)进行龋病管理的证据。
一种通过风险评估进行龋齿管理的系统(CAMBRA®)已经在加州开发出来。本文的目的是总结方法背后的科学,CAMBRA的发展历史,以及临床应用的结果。CAMBRA龋齿风险评估(CRA)工具已在加州大学旧金山分校(UCSF)使用了14年,并进行了涉及数千名患者的结果研究。三个结果评估,每个在不同的患者队列中,显示了CAMBRA-CRA风险水平低,中等,高和极端与随访时牙本质空化或病变(通过x线片)之间的明确关系。这种经过验证的风险预测工具已经随着时间的推移而更新,现在作为常规临床实践的一部分在UCSF和世界各地的其他环境中使用。CAMBRA-CRA工具对0- 5岁儿童具有相似的预测效度,并已被常规使用。根据龋齿风险状况,在传统的恢复性治疗方案中加入化学疗法(抗菌加氟化物),可使龋齿高风险成年患者的龋齿增量减少约20%至38%。高危患者使用的化学疗法是每日抗菌治疗(0.12% w/v的葡萄糖酸氯己定漱口水)和每日两次的高浓度氟化物牙膏(5000 ppm F)的组合,均为家庭使用。这些结果评估为自信地使用这些CRA工具提供了证据。可以根据评估的龋齿风险水平,加上必要的修复程序,通过添加化学治疗来治疗龋齿。对于高危和极危患者,抗菌和氟化物联合治疗是必要的。氟化物治疗必须辅以抗菌治疗,以减少细菌的挑战,改变生物膜,并提供预防,而不是继续蛀牙的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in Dental Research
Advances in Dental Research Medicine-Medicine (all)
CiteScore
8.20
自引率
0.00%
发文量
0
期刊最新文献
Women in Dental Clinical and Translational Research. Geroscience: Aging and Oral Health Research. Commentary: Challenges and Opportunities for Women in Dental Research Then and Now—A Look Inside the Lives of 11 Women Presidents of the IADR Women Recipients of IADR Distinguished Scientist Awards
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1